Downloadable Slidesets


Share

Program Content

Activities

  • Frontline Therapy for CLL
    Optimal Selection of Therapy for Treatment-Naive CLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 03, 2020

    Expires: December 02, 2021

  • Treating R/R CLL
    Considerations in Selecting Therapy for Previously Treated CLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • Future Directions in CLL
    Near Future Directions: Promising Agents and Combinations Under Investigation
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • <i>EP</i>: Personalized Tx in CLL
    ExpressPoints Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2020

    Expires: December 08, 2021

Faculty

cover img faculity

Jeremy S. Abramson, MD, MMSc

Director, Center for Lymphoma
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Brian T. Hill, MD, PhD

Director, Lymphoid Malignancies Program
Staff Physician, Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

cover img faculity

William G. Wierda, MD, PhD

Associate Professor of Medicine
Department of Leukemia
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from

AstraZeneca Pharmacyclics AbbVie

Janssen administered by Scientific Affairs

Lilly